Sangamo Therapeutics Inc Stock Ownership - Who owns Sangamo Therapeutics?

Insider buying vs selling

Have Sangamo Therapeutics Inc insiders been buying or selling?
Biogen Inc10% Owner2022-08-30100,000$5.27
Biogen Inc10% Owner2022-08-29400,000$5.33
Scott B. WilloughbySVP Gen. Counsel & Secretary2022-08-13864$6.33
David Mark McClungEVP Chief Operating Officer2022-06-2511,525$4.31
Prathyusha DuraibabuVice President Finance2022-06-11842$3.76
Prathyusha DuraibabuSVP Chief Financial Officer2022-06-11864$3.76
John MarkelsDirector2022-06-036,784$3.69
H. Stewart ParkerDirector2022-06-015,000$3.60
Scott B. WilloughbySVP Gen. Counsel & Secretary2022-04-29140$4.15
Jason D. FontenotSVP Chief Scientific Officer2022-04-25826$4.83

1 of 2

SGMO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMO insiders and whales buy or sell their stock.

SGMO Shareholders

What type of owners hold Sangamo Therapeutics Inc stock?
Biogen Inc14.43%23,652,466$83.02MInsider
Blackrock Inc8.70%14,264,458$50.07MInstitution
Wasatch Advisors Inc8.01%13,122,116$46.06MInstitution
Vanguard Group Inc7.77%12,731,109$44.69MInstitution
State Street Corp4.25%6,968,276$24.46MInstitution
Credit Suisse Ag 12.32%3,803,127$13.35MInstitution
Ra Capital Management LP2.25%3,683,002$12.93MInsider
Nuveen Asset Management LLC2.05%3,355,829$11.78MInstitution
Dimensional Fund Advisors LP1.87%3,070,841$10.78MInstitution
Rokos Capital Management LLP1.85%3,026,210$10.62MInstitution

1 of 3

SGMO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMO59.34%20.42%Net Selling
HLVX56.19%43.81%Net Buying
CERS82.47%3.84%Net SellingNet Buying
TNGX66.03%33.97%Net Buying
ARDX23.10%76.90%Net SellingNet Buying

Sangamo Therapeutics Stock Ownership FAQ

Who owns Sangamo Therapeutics?

Sangamo Therapeutics (NASDAQ: SGMO) is owned by 59.34% institutional shareholders, 20.42% Sangamo Therapeutics insiders, and 20.24% retail investors. Biogen Inc is the largest individual Sangamo Therapeutics shareholder, owning 23.65M shares representing 14.43% of the company. Biogen Inc's Sangamo Therapeutics shares are currently valued at $83.02M.

If you're new to stock investing, here's how to buy Sangamo Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.